Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000003

Chief Medical Officer acquired 31,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2022-01-03 Grant or award +31,000 107,316 D
Derivatives
Ho Carole Chief Medical Officer 2022-01-03 Grant or award · Stock Option (right to buy) +93,000 93,000 D
Loading xslF345X03/wf-form4_164142741424082.xml…